| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. | Cancer Res | 1999 | 2.96 |
| 2 | Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer. | Semin Oncol | 2001 | 0.79 |